WASHINGTON, D.C. (August 12, 2022) – The Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Stephen J. Ubl released the following statement after the U.S. House of Representatives passed a reconciliation spending bill, which includes a proposal that would allow the government to set prices for prescription medicines:

“After many months of legislative wrangling, we are left with a partisan, government price setting bill that will lead to fewer cures and treatments and doesn’t do nearly enough to make medicines more affordable for most Americans. It is a highly unbalanced bill based on empty promises. We will continue to advocate for commonsense and bipartisan solutions because the American people deserve better.”